Skanska AB (SKBSY, SKSBF, SKA-B.ST), a Swedish construction and project development company, on Monday announced that it has signed an additional contract worth $116 million or about 1.2 billion Swedish Krona with the University of Virginia for the construction of the Paul and Diane Manning Institute of Biotechnology at Fontaine Research Park in Charlottesville.
The construction began in December 2023 and is expected to finish in the fourth quarter of 2027.
The amount will be included in U.S. order bookings for the third quarter of 2025.
The five-story, 33,000-square-meter or 354,000-square-foot facility will house the Commonwealth's first translational research program, featuring modular and multi-use laboratories, core facilities, and space for 100 to 150 researchers and biotechnology companies.
On Friday, Skanska closed trading, 0.99% lesser at SEK 241 on the Stockholm Stock Exchange.
For comments and feedback contact: editorial@rttnews.com
Business News
April 24, 2026 15:15 ET Economics news flow was relatively light this week even as the conflict in the Middle East continued, raising concerns for policymakers. In the U.S., spending data, initial jobless claims and pending home sales were the highlights. Business confidence in the biggest euro area economy was in focus in Europe. Inflation data from Japan gained attention in Asia.